Skip to content

    Unihealth Hosp

    UNIHEALTH
    Healthcare·18 Nov 2025
    Management Summary

    Unihealth Hospitals Limited reported a robust H1 FY26, with consolidated total income growing 55% to INR70 crore and net profit tripling to INR28.6 crores, driven by strong operational momentum in India and Africa. EBITDA margin expanded significantly to 49.76%. While new Indian facilities faced initial delays and margin pressure, the company is expanding its footprint and service depth, targeting a 1,000-bed integrated platform by FY27-28. Receivables, primarily from Uganda's Ministry of Defense, remain a watch item.

    Highlights

    7
    • Consolidated total income grew by 55% to INR70 crore, driven by strong traction in hospital operations and allied businesses.

    • EBITDA more than doubled to INR35 crore, with EBITDA margin expanding 1,212 basis points to 49.76%.

    • Consolidated net profit more than tripled to INR28.6 crores, with profit attributable to equity shareholders increasing from INR5.12 crores to INR15.1 crores.

    • EPS improved significantly to INR9.8, reflecting strong profitability.

    • Uganda business received a 10-year income tax holiday effective July 1, 2024, leading to significant tax savings.

    • Navi Mumbai 52-bed facility is now fully operational, and Nashik 200-bed hospital is progressing well for commissioning early next calendar year.

    • Uganda's ARPOB increased from 24,000-25,000 last year to over 40,000+ in H1 FY26, driven by super specialties and ICU beds.

    Concerns

    3
    • Receivables increased to INR112 crores as of September 30, 2025, with INR82.08 crores from Uganda People's Defense Forces, which has a 9-13 month payment cycle.

    • Initial EBITDA margins for new Indian facilities (Navi Mumbai, Nashik) are expected to be pressurized (15-20%) due to startup costs, marketing, and consultant onboarding.

    • Commissioning of Navi Mumbai and Nashik facilities experienced some delays due to statutory approvals and festive periods.

    Key financials

    Single quarter

    09 metrics
    1. 01Consolidated Total Income₹70 Cr+55.0%YoY
    2. 02Consolidated EBITDA₹35 Cr
    3. 03Consolidated EBITDA Margin49.8%
    4. 04Consolidated Net Profit₹28.6 Cr
    5. 05Profit Attributable to Shareholders₹15.1 Cr

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Navi Mumbai from IPO proceeds; Nashik via equity contribution and sanctioned bank debt; Tanzania secondary care via internal approvals and equity; newer projects (Tanzania 100-bed, Pune) partly internal accruals, partly banking facility, some capital leasing.

    Debt

    Debt disclosed

    Liquidity

    Liquidity disclosed

    Uganda's debt repayment will free up cash flow for capital investments and debt repayment to UniHealth Hospitals Limited, which can then be reallocated for expansion in India and Tanzania.

    Guidance & targets

    19
    CategoryTargetPriority
    Capacity
    Total bed capacity
    1,000 beds
    High
    Capacity
    India bed capacity
    500-600 beds
    High
    Capacity
    Africa bed capacity
    400+ beds
    High
    Commissioning
    Mwanza, Tanzania secondary care hospital
    Operational
    High
    Commissioning
    Nashik hospital
    Commissioning
    High
    Revenue
    Navi Mumbai annual revenue
    INR30 crores
    High
    Revenue
    Nashik annual revenue
    INR100 crores
    High
    Revenue
    Combined India (Navi Mumbai + Nashik) top line
    INR125 crores
    High
    Margin
    Combined India (Navi Mumbai + Nashik) EBITDA margin
    15-18%
    High
    Margin
    Navi Mumbai EBITDA margin
    24-25%
    High
    Occupancy
    Navi Mumbai occupancy rate
    60-70%
    High
    Occupancy
    Nashik occupancy rate
    50%
    High
    ARPOB
    Uganda ARPOB
    55,000-60,000
    High
    ARPOB
    India ARPOB
    55,000-60,000
    High
    Receivables
    India receivable days
    30-45 days
    High
    Receivables
    Tanzania (NHIF) receivable days
    75-100 days
    High
    Revenue Contribution
    Uganda revenue share
    50-60%
    High
    Revenue Contribution
    India revenue share
    40-50%
    High
    Tax Rate
    Uganda income tax holiday
    10 years
    High

    Nashik hospital commissioning and initial occupancy

    Next quarter (Q4 FY26)
    CurrentProgressing well, targeting early next calendar year (Jan/Feb) for commissioning
    TargetCommissioning complete, initial occupancy rate (target ~50%)

    Why it matters

    Nashik is a significant 200-bed facility, and its successful commissioning and ramp-up are crucial for India's growth strategy.

    Regarding Nashik, the intended plan was December. We still are working towards it. The facility is nearly complete. Installations of various equipments are going on right now. This process will be completed by December. Statutory approvals, again, are something that the applications have begun with. We are waiting for an exact timeline related to that. Based on our experience in Navi Mumbai, we anticipate that some of these statutory approvals might take a bit longer. And that is the only reason that we redefined the commissioning date to next calendar year. We are looking at maybe sometime around January, February for all approvals to come in and commission the services in totality.

    How to verify

    guidance_and_targets[metric='Nashik hospital'][target_period='early next calendar year (Jan/Feb)']

    Risks & concerns

    4
    RiskSeverity

    High receivables from Uganda People's Defense Forces

    INR82.08 crores out of INR112 crores total receivables are from Uganda military, with a 9-13 month payment cycle, though historically reliable.Analyst acknowledged

    medium

    Initial margin pressure for new Indian facilities

    New facilities in Navi Mumbai and Nashik will experience pressurized EBITDA margins (15-20%) initially due to startup costs, marketing, and consultant onboarding.Management acknowledged

    medium

    Delays in statutory approvals for new facilities

    Navi Mumbai commissioning was delayed due to statutory approvals and festive periods; similar delays are anticipated for Nashik.Management acknowledged

    low

    Revenue dip during festive season in Uganda

    Uganda typically sees a dip in revenue between December 15 and January 15 due to people traveling out of the country and deferring elective procedures.Management acknowledged

    low

    Q&A highlights

    8

    “So, of the INR112 crores, almost INR82 odd crores, INR82.08 crores is the outstanding to be received from the Ugandan military or the Ministry of Defense. Now, over the last few years, three to four years that we have been catering to them with respect to the healthcare services, there has never been a challenge with respect to under-recovery or the risk of bad debt because it is eventually the Government of Uganda, which is the payer. And their cycle for payment is between about nine months to 12, 13 months. But the payments come in that cyclical manner over the years.”

    Addresses a key concern about high receivables, explaining the primary source (Uganda military) and its payment cycle, while outlining a strategy for India to focus on cash/insurance patients for better working capital.

    asked by Shubham Jain

    3 min read6 chapters

    Detailed Narrative

    01

    Strong H1 FY26 Financial Performance Driven by Operational Momentum

    Unihealth Hospitals Limited delivered a very strong financial performance in H1 FY26. Consolidated total income grew by 55% to INR70 crore, with EBITDA more than doubling to INR35 crore. This led to a significant expansion in EBITDA margin by 1,212 basis points, reaching 49.76%. The consolidated net profit more than tripled to INR28.6 crores, and profit attributable to equity shareholders increased from INR5.12 crores to INR15.1 crores, resulting in an improved EPS of INR9.8. This robust performance is attributed to rising patient volumes, broader specialty coverage, and steady execution across India and Africa.

    02

    Strategic India Expansion Taking Shape with New Facilities

    The company's India expansion is progressing as planned with an asset-light model. The 52-bed facility in Navi Mumbai was commissioned in October 2025, following minor delays due to statutory approvals. For FY26, Navi Mumbai is targeted to achieve an annualized revenue of over INR30 crores with 60-70% occupancy. The upcoming 200-bed Nashik hospital, equipped with advanced medical infrastructure, is expected to be commissioned early next calendar year (Jan/Feb 2026), targeting an annualized revenue of INR100 crores with 50% occupancy in its first full year. Combined, these Indian facilities are targeted to achieve INR125 crores in top line for the next financial year, with an initial EBITDA margin of 15-18%.

    03

    Uganda Operations: High ARPOB and Tax Holiday Benefits

    Africa remains a strong pillar of performance, with Uganda contributing the largest share of growth. The Uganda unit achieved an ARPOB of over 40,000+ in H1 FY26, significantly up from 24,000-25,000 last year, with an occupancy rate of approximately 72% on its 120 beds. This growth was driven by the addition of super specialties like IVF, ICU beds, and increased frequency of Indian doctors conducting surgical camps. Furthermore, the Uganda business benefits from a 10-year income tax holiday effective July 1, 2024, which is a significant tax saving for the company. The company aims for Uganda's ARPOB to reach 55,000-60,000 in the next 12 months.

    04

    Receivables Management and Evolving Payor Mix

    Consolidated receivables stood at INR112 crores as of September 30, 2025, with a major portion (INR82.08 crores) from the Uganda People's Defense Forces, which has a payment cycle of 9-13 months. However, the company notes that these payments are eventually from the Government of Uganda and have historically been reliable. With the expansion in India, the company plans to focus on cash and insurance patients, expecting receivable days to be within 30-45 days. In Tanzania, payments from the National Health Insurance Fund (NHIF) are expected within 75-100 days. These changes are anticipated to reduce the consolidated trade receivable days going forward.

    05

    Africa Expansion and Future Growth Drivers

    Beyond Uganda, Unihealth is expanding its African footprint. A new secondary care hospital in Mwanza, Tanzania, is expected to be operational by the end of this financial year. The company is also in advanced stages of discussions to take over the operational management of a 100-bed tertiary care specialty hospital in Tanzania, aiming for it to be effective from April 1, 2026. Overall, Unihealth plans to add another 400+ beds in Africa over the next two to three years. The company's integrated India-Africa model aims for a 1,000-bed platform by the end of calendar year 2027 (FY27-28).

    06

    Consultancy Vertical and Project Pipeline

    The consultancy vertical continues to be a strong contributor, currently managing over 1,300 beds across India and Africa. This segment adds high-margin revenue, strengthens institutional partnerships, and expands the project pipeline. The company is in discussions for an additional 600-650 beds in terms of total project size, awaiting financial closure from investors. Unihealth is also involved in a large project in Pune (14 acres, 1.2 million sqft) as a project management consultant, with commissioning expected in 3.5-5 years. Pune is also targeted for a 125+ bed tertiary care facility expansion in the next financial year.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.